Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage

AI Briefing

• – Bioxodes appoints neurovascular experts to Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage, company in dialogue with regulators
• – Bioxodes SA develops novel therapies for thrombotic and inflammatory diseases
• – Company aims to treat intracerebral hemorrhage with BIOX-101